Effect of Virtual Reality on Depression in Adolescent Females

Sponsor
Cairo University
Study ID
NCT07452341
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
FEMALE
Age
13 Years - 18 Years
Healthy Volunteers
Not accepted

Interventions

  • Virtual reality headset — DEVICE
    Participants will use virtual reality glasses during treatment sessions for approximately 30 minutes per session, once per week for 8 weeks .
  • Selective serotonin reuptake inhibitors(SSRIs) — DRUG
    All adolescent females in the control group will receive antidepressant drugs Selective serotonin reuptake inhibitors(SSRIs) for 8 weeks as described by the psychiatrist

Study Details

The purpose of this study is to investigate the effect of virtual reality on depression in adolescent females.

Key Dates

First listed
Mar 5, 2026
Start date
Aug 1, 2026
Status verified
Mar 2026
Primary completion
Jan 1, 2027
Completion
Feb 1, 2027

Study Design

Enrollment
48 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Drug + virtual reality group
    24 Participants in this group will receive the same standard drug therapy(Selective serotonin reuptake inhibitors(SSRIs) in addition to virtual reality exposure using VR headset during the treatment sessions.
  • Active Comparator: Drug only group (controlled)
    24 participants will receive antidepressant drugs Selective serotonin reuptake inhibitors(SSRIs) only

Primary Outcome Measure

1-Calculation the score of Beck Depression Inventory [BDI] to assess the severity of depression. [ Time Frame: 8 weeks ]

Find similar trials

Nationwide
Depression trialsPsychiatry trialsMental health trialsBehavioral health trials

Related Studies